Cargando…
Prognostic Significance of miR-181b and miR-21 in Gastric Cancer Patients Treated with S-1/Oxaliplatin or Doxifluridine/Oxaliplatin
BACKGROUND: The goal of this study is to evaluate the effectiveness of S-1/Oxaliplatin vs. Doxifluridine/Oxaliplatin regimen and to identify miRNAs as potential prognostic biomarkers in gastric cancer patients. The expression of candidate miRNAs was quantified from fifty-five late stage gastric canc...
Autores principales: | Jiang, Jingting, Zheng, Xiao, Xu, Xiao, Zhou, Qi, Yan, Haijiao, Zhang, Xueguang, Lu, Binfeng, Wu, Changping, Ju, Jingfang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3158077/ https://www.ncbi.nlm.nih.gov/pubmed/21876743 http://dx.doi.org/10.1371/journal.pone.0023271 |
Ejemplares similares
-
miR-135a promotes gastric cancer progression and resistance to oxaliplatin
por: Yan, Lin-Hai, et al.
Publicado: (2016) -
Diagnosis value of miR‐181, miR‐652, and CA72‐4 for gastric cancer
por: Tian, Wenyan, et al.
Publicado: (2022) -
Up-Regulation of miR-21, miR-25, miR-93, and miR-106b in Gastric Cancer
por: Larki, Pegah, et al.
Publicado: (2018) -
MiR-21, miR-34a, miR-125b, miR-181d and miR-648 levels inversely correlate with MGMT and TP53 expression in primary glioblastoma patients
por: Jesionek-Kupnicka, Dorota, et al.
Publicado: (2017) -
miR-454 promotes survival and induces oxaliplatin resistance in gastric carcinoma cells by targeting CYLD
por: Huang, Chaoqun, et al.
Publicado: (2020)